常州市存仁生物工程有限公司

Erlotinib hydrochloride|埃罗替尼

Erlotinib hydrochloride|埃罗替尼

Description of:Erlotinib hydrochloride|埃罗替尼
Erlotinib is an inhibitor of human Epidermal growth factor receptor (EGFR) tyrosine kinase (IC50 = ...
更多>>
AST-6

AST-6

Description of:AST-6
AST-6, a rationally designed novel anilino-quinazoline compound, inhibited enzymatic activities of wild type EGFR and ErbB...
更多>>
TAK 285

TAK 285

Description of:TAK 285
 TAK-285 is currently under clinical development. TAK-285 may have a unique role in the treatment of brain lesions ...
更多>>
AEE788

AEE788

Description of:AEE788
AEE788 demonstrated antiproliferative activity against a range of EGFR and ErbB2-overexpressing cell lines and inhibited ...
更多>>
CUDC-101

CUDC-101

Description of:CUDC-101
 This drug has novel structure incorporating HDAC inhibitory functionality into the pharmacophore of the EGFR and ...
更多>>
Afatinib

Afatinib

Description of:Afatinib
Afatinib is an irreversible EGFR/HER2 inhibitor with an IC50 of 14 nM for in vitro potency against HER2.
Theor...
更多>>
BMS690514

BMS690514

Description of:BMS690514
BMS-690514 is currently under investigation as an oral agent for the treatment of solid tumors. In vitro and in vivo s...
更多>>
AG-490

AG-490

Description of:AG-490
AG490 inhibits the proliferation of several cell types including leukemia cells and fibroblasts. AG490 is also selective ...
更多>>
总数: 8 页: 1 / 1 首页 ←上一页 下一页→ 末页